Home	Fast Track My Amedeo FAQ About	Flying Publisher
Fast Track	FPG #8: Alternative Treatments in Psychiatry FPG #7: Critical Care in Neurology	Free Medical Books

Malignant Lymphoma

Free Subscription Articles published in Cancer Retrieve available abstracts of 57 articles: HTML format Text format

Single Articles

January 2012
1. CAMIDGE DR , Theodoro M, Maxson DA, Skokan M, et al
   Correlations between the percentage of tumor cells showing an ALK (anaplastic lymphoma kinase) gene rearrangement, ALK signal copy number, and response to crizotinib therapy in ALK fluorescence in situ hybridization-positive nonsmall cell lung cancer.
   Cancer. 2012 Jan 26. doi: 10.1002/cncr.27411.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
2. RAMALINGAM SS , Khuri FR
   Lung cancer with translocation in the anaplastic lymphoma kinase gene: A disease within a disease.
   Cancer. 2012 Jan 26. doi: 10.1002/cncr.27402.
   PubMed     Text format     Related articles   
   
   
   
   
3. SUGAWARA E , Togashi Y, Kuroda N, Sakata S, et al
   Identification of anaplastic lymphoma kinase fusions in renal cancer: Large-scale immunohistochemical screening by the intercalated antibody-enhanced polymer method.
   Cancer. 2012 Jan 17. doi: 10.1002/cncr.27391.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
4. CAMPBELL BA , Connors JM, Gascoyne RD, Morris WJ, et al
   Limited-stage diffuse large B-cell lymphoma treated with abbreviated systemic therapy and consolidation radiotherapy: Involved-field versus involved-node radiotherapy.
   Cancer. 2012 Jan 17. doi: 10.1002/cncr.26687.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
5. SHIMONI A , Avivi I, Rowe JM, Yeshurun M, et al
   A randomized study comparing yttrium-90 ibritumomab tiuxetan (Zevalin) and high-dose BEAM chemotherapy versus BEAM alone as the conditioning regimen before autologous stem cell transplantation in patients with aggressive lymphoma.
   Cancer. 2012 Jan 17. doi: 10.1002/cncr.27418.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   December 2011
6. AKYUREK N , Uner A, Benekli M, Barista I, et al
   Prognostic significance of MYC, BCL2, and BCL6 rearrangements in patients with diffuse large B-cell lymphoma treated with cyclophosphamide, doxorubicin, vincristine, and prednisone plus rituximab.
   Cancer. 2011 Dec 27. doi: 10.1002/cncr.27396.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
7. TAKAHASHI H , Tomita N, Yokoyama M, Tsunoda S, et al
   Prognostic impact of extranodal involvement in diffuse large B-cell lymphoma in the rituximab era.
   Cancer. 2011 Dec 27. doi: 10.1002/cncr.27381.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
8. MATO AR , Svoboda J, Feldman T, Zielonka T, et al
   Post-treatment (not interim) positron emission tomography-computed tomography scan status is highly predictive of outcome in mantle cell lymphoma patients treated with R-HyperCVAD.
   Cancer. 2011 Dec 16. doi: 10.1002/cncr.26731.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
9. BARTA SK , Lee JY, Kaplan LD, Noy A, et al
   Pooled analysis of AIDS malignancy consortium trials evaluating rituximab plus CHOP or infusional EPOCH chemotherapy in HIV-associated non-Hodgkin lymphoma.
   Cancer. 2011 Dec 16. doi: 10.1002/cncr.26723.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
10. RAIZER JJ , Rademaker A, Evens AM, Rice L, et al
    Pemetrexed in the treatment of relapsed/refractory primary central nervous system lymphoma.
    Cancer. 2011 Dec 16. doi: 10.1002/cncr.26709.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
11. FERRARIO A , Pulsoni A, Olivero B, Rossi G, et al
    Fludarabine, cyclophosphamide, and rituximab in patients with advanced, untreated, indolent B-cell nonfollicular lymphomas: Phase 2 study of the Italian Lymphoma Foundation.
    Cancer. 2011 Dec 16. doi: 10.1002/cncr.26708.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
12. SHARAIHA RZ , Lebwohl B, Reimers L, Bhagat G, et al
    Increasing incidence of enteropathy-associated T-cell lymphoma in the United States, 1973-2008.
    Cancer. 2011 Dec 13. doi: 10.1002/cncr.26700.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
13. JIANG M , Zhang H, Jiang Y, Yang Q, et al
    Phase 2 trial of "Sandwich" L-asparaginase, vincristine, and prednisone chemotherapy with radiotherapy in newly diagnosed, stage IE to IIE, nasal type, extranodal natural killer/T-cell lymphoma.
    Cancer. 2011 Dec 2. doi: 10.1002/cncr.26629.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    November 2011
14. LEE JK , Park HS, Kim DW, Kulig K, et al
    Comparative analyses of overall survival in patients with anaplastic lymphoma kinase-positive and matched wild-type advanced nonsmall cell lung cancer.
    Cancer. 2011 Nov 15. doi: 10.1002/cncr.26668.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    October 2011
15. KUMAR A , Vanderplas A, Lacasce AS, Rodriguez MA, et al
    Lack of benefit of central nervous system prophylaxis for diffuse large B-cell lymphoma in the rituximab era: Findings from a large national database.
    Cancer. 2011 Oct 17. doi: 10.1002/cncr.26588.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
16. CHESON BD , Bartlett NL, Vose JM, Lopez-Hernandez A, et al
    A phase II study of the survivin suppressant YM155 in patients with refractory diffuse large B-cell lymphoma.
    Cancer. 2011 Oct 17. doi: 10.1002/cncr.26510.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    August 2011
17. LIN P , Dickason TJ, Fayad LE, Lennon PA, et al
    Prognostic value of MYC rearrangement in cases of B-cell lymphoma, unclassifiable, with features intermediate between diffuse large B-cell lymphoma and Burkitt lymphoma.
    Cancer. 2011 Aug 31. doi: 10.1002/cncr.26433.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
18. SHANAFELT TD , Kay NE, Rabe KG, Inwards DJ, et al
    Hematologist/oncologist disease-specific expertise and survival: Lessons from chronic lymphocytic leukemia (CLL)/small lymphocytic lymphoma (SLL).
    Cancer. 2011 Aug 26. doi: 10.1002/cncr.26474.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
19. LU NN , Li YX, Wang WH, Jin J, et al
    Clinical behavior and treatment outcome of primary nasal diffuse large B-cell lymphoma.
    Cancer. 2011 Aug 11. doi: 10.1002/cncr.26452.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    July 2011
20. CABANILLAS ME , Kantarjian H, Thomas DA, Mattiuzzi GN, et al
    Epoetin alpha decreases the number of erythrocyte transfusions in patients with acute lymphoblastic leukemia, lymphoblastic lymphoma, and Burkitt leukemia/lymphoma: Results of a Randomized Clinical Trial.
    Cancer. 2011 Jul 12. doi: 10.1002/cncr.26341.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
21. CARBONE A
    Does "in situ lymphoma" occur as a distinct step in the development of nodular lymphocyte-predominant Hodgkin lymphoma?
    Cancer. 2011 Jul 5. doi: 10.1002/cncr.26228.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    June 2011
22. MILANO MT , Li H, Constine LS, Travis LB, et al
    Survival after second primary lung cancer: A population-based study of 187 hodgkin lymphoma patients.
    Cancer. 2011 Jun 20. doi: 10.1002/cncr.26257.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
23. SROKOWSKI TP , Liebmann JE, Modiano MR, Cohen GI, et al
    Pixantrone dimaleate in combination with fludarabine, dexamethasone, and rituximab in patients with relapsed or refractory indolent non-Hodgkin lymphoma: Phase 1 Study With a Dose-Expansion Cohort.
    Cancer. 2011 Jun 16. doi: 10.1002/cncr.26121.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    May 2011
24. GUIDETTI A , Carlo-Stella C, Ruella M, Miceli R, et al
    Myeloablative doses of yttrium-90-ibritumomab tiuxetan and the risk of secondary myelodysplasia/acute myelogenous leukemia.
    Cancer. 2011 May 12. doi: 10.1002/cncr.26182.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
25. DIETRICH S , Tielesch B, Rieger M, Nickelsen M, et al
    Patterns and outcome of relapse after autologous stem cell transplantation for mantle cell lymphoma.
    Cancer. 2011;117:1901-10.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    April 2011
26. LI YX , Liu QF, Wang WH, Jin J, et al
    Failure patterns and clinical implications in early stage nasal natural killer/T-cell lymphoma treated with primary radiotherapy.
    Cancer. 2011 Apr 26. doi: 10.1002/cncr.26167.
    PubMed     Text format     Related articles   
    
    
    
    
27. HERNANDEZ-ILIZALITURRI FJ , Deeb G, Zinzani PL, Pileri SA, et al
    Higher response to lenalidomide in relapsed/refractory diffuse large b-cell lymphoma in nongerminal center b-cell-like than in germinal center b-cell-like phenotype.
    Cancer. 2011 Apr 14. doi: 10.1002/cncr.26135.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
28. KATZ SC , Baldwin K, Karakousis G, Moraco N, et al
    Soft tissue sarcoma diagnosed subsequent to lymphoma is associated with prior radiotherapy and decreased survival.
    Cancer. 2011 Apr 4. doi: 10.1002/cncr.26105.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
29. NABHAN C , Davis N, Bitran JD, Galvez A, et al
    Efficacy and safety of clofarabine in relapsed and/or refractory non-hodgkin lymphoma, including rituximab-refractory patients.
    Cancer. 2011;117:1490-7.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
30. LECHNER MG , Lade S, Liebertz DJ, Prince HM, et al
    Breast implant-associated, ALK-negative, T-cell, anaplastic, large-cell lymphoma: Establishment and characterization of a model cell line (TLBR-1) for this newly emerging clinical entity.
    Cancer. 2011;117:1478-89.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    March 2011
31. MATSUE K , Hayama BY, Iwama KI, Koyama T, et al
    High frequency of neurolymphomatosis as a relapse Disease of intravascular large B-cell lymphoma.
    Cancer. 2011 Mar 29. doi: 10.1002/cncr.26090.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
32. PICARSIC J , Jaffe R, Mazariegos G, Webber SA, et al
    Post-transplant burkitt lymphoma is a more aggressive and distinct form of post-transplant lymphoproliferative disorder.
    Cancer. 2011 Mar 28. doi: 10.1002/cncr.26001.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    February 2011
33. MUSOLINO A , Boggiani D, Panebianco M
    Reply to activity and safety of dose-adjusted infusional cyclophosphamide, doxorubicin, vincristine, and prednisone chemotherapy with rituximab in very elderly patients with poor-prognostic untreated diffuse large B-cell non-Hodgkin lymphoma.
    Cancer. 2011 Feb 1. doi: 10.1002/cncr.25962.
    PubMed     Text format     Related articles   
    
    
    
    
34. FABBRI A , Gozzetti A, Rigacci L
    Activity and safety of dose-adjusted infusional cyclophosphamide, doxorubicin, vincristine, and prednisone chemotherapy with rituximab in very elderly patients with poor-prognostic untreated diffuse large B-cell non-Hodgkin lymphoma.
    Cancer. 2011 Feb 1. doi: 10.1002/cncr.25948.
    PubMed     Text format     Related articles   
    
    
    
    December 2010
35. YANAI S , Nakamura S, Takeshita M, Fujita K, et al
    Translocation t(14;18)/IGH-BCL2 in gastrointestinal follicular lymphoma: correlation with clinicopathologic features in 48 patients.
    Cancer. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
36. SHENOY PJ , Malik N, Nooka A, Sinha R, et al
    Racial differences in the presentation and outcomes of diffuse large B-cell lymphoma in the United States.
    Cancer. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
37. O'ROURKE K , Morris K, Kennedy GA
    Intravenous methotrexate as central nervous system (CNS) prophylaxis is associated with a low risk of CNS recurrence in high-risk patients with diffuse large B-cell lymphoma.
    Cancer. 2010.
    PubMed     Text format     Related articles   
    
    
    
    
38. ABRAMSON JS , Hochberg EP
    Intravenous methotrexate as central nervous system (CNS) prophylaxis is associated with a low risk of CNS recurrence in high-risk patients with diffuse large B-cell lymphoma.
    Cancer. 2010.
    PubMed     Text format     Related articles   
    
    
    
    
39. BAIOCCHI RA , Alinari L, Lustberg ME, Lin TS, et al
    Phase 2 trial of rituximab and bortezomib in patients with relapsed or refractory mantle cell and follicular lymphoma.
    Cancer. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
40. MAZLOOM A , Rodriguez A, Ha CS, Medeiros LJ, et al
    Incidence of gastric involvement in patients with nongastrointestinal extranodal marginal zone lymphoma.
    Cancer. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    November 2010
41. DIETRICH S , Tielesch B, Rieger M, Nickelsen M, et al
    Patterns and outcome of relapse after autologous stem cell transplantation for mantle cell lymphoma.
    Cancer. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
42. LECHNER MG , Lade S, Liebertz DJ, Prince HM, et al
    Breast implant-associated, ALK-negative, T-cell, anaplastic, large-cell lymphoma: Establishment and characterization of a model cell line (TLBR-1) for this newly emerging clinical entity.
    Cancer. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
43. NABHAN C , Davis N, Bitran JD, Galvez A, et al
    Efficacy and safety of clofarabine in relapsed and/or refractory non-hodgkin lymphoma, including rituximab-refractory patients.
    Cancer. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    October 2010
44. MUSOLINO A , Boggiani D, Panebianco M, Vasini G, et al
    Activity and safety of dose-adjusted infusional cyclophosphamide, doxorubicin, vincristine, and prednisone chemotherapy with rituximab in very elderly patients with poor-prognostic untreated diffuse large B-cell non-Hodgkin lymphoma.
    Cancer. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
45. CAMPBELL BA , Voss N, Woods R, Gascoyne RD, et al
    Erratum: Long-term outcomes for patients with limited stage follicular lymphoma.
    Cancer. 2010.
    PubMed     Text format     Related articles   
    
    
    
    
46. ZINZANI PL , Gandolfi L, Broccoli A, Argnani L, et al
    Midtreatment (18)F-fluorodeoxyglucose positron-emission tomography in aggressive non-Hodgkin lymphoma.
    Cancer. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
47. SIMARD EP , Pfeiffer RM, Engels EA
    Cumulative incidence of cancer among individuals with acquired immunodeficiency syndrome in the United States.
    Cancer. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
48. PETRICH A , Cho SI, Billett H
    Primary cardiac lymphoma: an analysis of presentation, treatment, and outcome patterns.
    Cancer. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    September 2010
49. MAZLOOM A , Medeiros LJ, McLaughlin PW, Reed V, et al
    Marginal zone lymphomas: factors that affect the final outcome.
    Cancer. 2010;116:4291-8.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
50. ARAKELYAN N , Jais JP, Delwail V, Briere J, et al
    Reduced versus full doses of irradiation after 3 cycles of combined doxorubicin, bleomycin, vinblastine, and dacarbazine in early stage Hodgkin lymphomas: results of a randomized trial.
    Cancer. 2010;116:4054-62.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    August 2010
51. ZINZANI PL , Broccoli A, Stefoni V, Musuraca G, et al
    Immunophenotype and intermediate-high international prognostic index score are prognostic factors for therapy in diffuse large B-cell lymphoma patients.
    Cancer. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
52. GODA JS , Gospodarowicz M, Pintilie M, Wells W, et al
    Long-term outcome in localized extranodal mucosa-associated lymphoid tissue lymphomas treated with radiotherapy.
    Cancer. 2010;116:3815-24.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    July 2010
53. SEABERG EC , Wiley D, Martinez-Maza O, Chmiel JS, et al
    Cancer incidence in the multicenter aids cohort study before and during the HAART era: 1984 to 2007.
    Cancer. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
54. FURMAN RR , Martin P, Ruan J, Cheung YK, et al
    Phase 1 trial of bortezomib plus R-CHOP in previously untreated patients with aggressive non-Hodgkin lymphoma.
    Cancer. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
55. GRUSCHKUS SK , Lairson D, Dunn JK, Risser J, et al
    Use of white blood cell growth factors and risk of acute myeloid leukemia or myelodysplastic syndrome among elderly patients with non-Hodgkin lymphoma.
    Cancer. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
56. DODERO A , Crocchiolo R, Patriarca F, Miceli R, et al
    Pretransplantation [18-F]fluorodeoxyglucose positron emission tomography scan predicts outcome in patients with recurrent Hodgkin lymphoma or aggressive non-Hodgkin lymphoma undergoing reduced-intensity conditioning followed by allogeneic stem cell tr
    Cancer. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    May 2010
57. JOSHUA TV , Rizzo JD, Zhang MJ, Hari PN, et al
    Access to hematopoietic stem cell transplantation: effect of race and sex.
    Cancer. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    

Thank you for your interest in scientific medicine.

Amedeo is a Flying Publisher website.    Design: